Business UpdateMay 20, 2026, 02:36 PM
LataMed AI Corp. (fka CCTC) Pivots to AI Healthcare, Acquires Assets
AI Summary
LataMed AI Corp. (formerly Catalyst Crew Technologies Corp.) announced a strategic pivot towards AI-enabled healthcare technology solutions focused on Latin America. This transition included the acquisition of proprietary healthcare technology assets for $7.93 million in common stock and the establishment of a Venezuelan subsidiary. The company reported a net loss of $52,813 for Q1 2026, an increase from the prior year, and faces substantial doubt about its ability to continue as a going concern. Management changes also occurred, with Kevin Rodan Levy appointed CEO and Carlos Peña as CFO.
Key Highlights
- Strategic pivot to AI-enabled healthcare technology solutions for Latin America.
- Acquired proprietary healthcare technology assets for $7,932,000 in common stock.
- Changed corporate name to LataMed AI Corp. from Catalyst Crew Technologies Corp.
- Established Venezuelan subsidiary, Inversiones Long 33, C.A., for Latin American strategy.
- Q1 2026 net loss was $52,813, compared to $24,455 in Q1 2025.
- Total assets increased to $7,824,000 from $0 as of December 31, 2025.
- Substantial doubt about the company's ability to continue as a going concern.
- Appointed Kevin Rodan Levy as CEO and Carlos Peña as CFO.
Price Impact
More from CCTC